Clinical Trial Update: Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

View source ↗

Summary

A completed clinical study update examining microRNA expression in acute graft-versus-host disease in patients receiving allogeneic stem cell transplants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Acute Graft-versus-Host Disease, Allogeneic Stem Cell Transplant | Status: COMPLETED